Oncology is a dynamic and diverse market. In 2017, oncology is estimated to lead all therapeutic areas in medicine spending (excluding supportive care) by developed nations, with revenues of $74–$84 billion. In pharmerging nations, it will to be the fourth-largest area, with $17–$20 billion in revenues. In 2013, global sales of oncology drugs totaled $37.2 […]

AB SCIEX introduced the Triple Quad 3500 MS, a lower-tier triple-quadrupole LC/MS system, which replaces the API 3200. The system features improvements in scan speed, polarity switching and sensitivity over its predecessor. Designed for routine food- and environmental-testing labs, the system employs the TurboV ion source for reliable quantitation over a wide range of flow […]

Hilden, Germany and Germantown, MD 5/30/14—QIAGEN disclosed as part of an announcement of a codevelopment deal with Eli Lilly and Company for companion diagnostics, that it has acquired PrimeraDx. All PrimeraDx employees have joined QIAGEN. PrimeraDx’s multimodal, multianalyte platform enables the simultaneous single-assay analysis of dozens of DNA and RNA biomarkers, their copy numbers, expression […]

Surrey, UK 6/18/14—Spectris has acquired Canadian company La Corporation Scientifique Claisse, a provider of sample preparation consumables and instruments for atomic spectroscopy analysis, for an undisclosed amount. Claisse had annual revenues ending March 2014 of CAD 13 million ($12 million = CAD 1.05 = $1). Claisse will become part of Spectris’s PANalytical business, which makes […]

Pleasanton, CA 6/26/14—Roche has made a strategic investment in Stratos Genomics and will collaborate with the company on research related to Stratos’s chemistry for single-molecule sequencing of DNA fragments using protein nanopores. The companies will work to develop efficient, low-cost sample preparation methods for DNA Xpandomers, a larger surrogate molecule, and to improve sequencing performance. […]

Minneapolis, MN 6/17/14—Techne (doing business as Bio-Techne), a provider of bioactive tools and resources for research and clinical diagnostics, has agreed to acquire ProteinSimple for $300 million in cash. ProteinSimple develops and commercializes systems and consumables for protein analysis, including products for automated Western blotting. For the 12 months ending May 31, ProteinSimple revenues grew […]